Tag: Oxford University

Gilead Sciences to acquire British biotech company MiroBio for $405m

pallavi123- August 6, 2022

Gilead Sciences has agreed to acquire MiroBio, a clinical-stage British biotech company, in an all-cash deal worth around $405 million in a move to gain ... Read More

India approves Serum Institute’s Covishield and Bharat Biotech’s Covaxin vaccines

pharmanewsdaily- January 3, 2021

The Drugs Controller General of India (DCGI) has granted emergency approvals to Serum Institute of India’s Covishield and Bharat Biotech's Covaxin vaccines for the prevention ... Read More

India approves Serum Institute’s Covishield and Bharat Biotech’s Covaxin vaccines

pharmanewsdaily- January 3, 2021

The Drugs Controller General of India (DCGI) has granted emergency approvals to Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin vaccines for the prevention ... Read More

Oxford develops rapid diagnostic test to detect Covid-19 within 5mins

pharmanewsdaily- October 16, 2020

Oxford University claimed that scientists from its Physics department have developed an extremely rapid diagnostic test for Covid-19. The rapid diagnostic test can detect and ... Read More

COV001 clinical trial results : Oxford vaccine ChAdOx1 nCoV-19 triggers strong immune response

pharmanewsdaily- July 20, 2020

COV001 clinical trial results : AstraZeneca and Oxford University said that interim results from the phase 1/2 COV001 clinical trial showed the ChAdOx1 nCoV-19 vaccine ... Read More

ChAdOx1 nCoV-19 vaccine : Russia’s R-Pharm signs deal with AstraZeneca

pharmanewsdaily- July 17, 2020

Russian pharma company R-Pharm has reportedly signed an agreement with AstraZeneca for manufacturing the ChAdOx1 nCoV-19 vaccine being developed by the latter in collaboration with ... Read More

Oxford University ChAdOx1 nCoV-19 vaccine trial begins in humans

pharmanewsdaily- April 25, 2020

Researchers at the University of Oxford in the UK have commenced the ChAdOx1 nCoV-19 vaccine trial in healthy human volunteers to test the vaccine candidate's ... Read More

Evox Therapeutics raises £35.5m to advance exosome therapeutics

pharmanewsdaily- September 4, 2018

Evox Therapeutics, an Oxford biotech spinout focused on developing exosome therapeutics, has raised £35.5 million from a Series B financing round led by Redmile Group ... Read More